125 related articles for article (PubMed ID: 8788438)
41. The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B.
Scarlota LC; Harvey JA; Aloyo VJ
Psychopharmacology (Berl); 2011 Feb; 213(2-3):393-401. PubMed ID: 20652541
[TBL] [Abstract][Full Text] [Related]
42. Stimulation of median, but not dorsal, raphe 5-HT1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat.
Wadenberg ML; Hillegaart V
Neuropharmacology; 1995 May; 34(5):495-9. PubMed ID: 7566483
[TBL] [Abstract][Full Text] [Related]
43. [Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum].
Ishikane T
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):441-9. PubMed ID: 9846274
[TBL] [Abstract][Full Text] [Related]
44. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
[TBL] [Abstract][Full Text] [Related]
45. Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats.
Wadenberg MG; Sills TL; Fletcher PJ; Kapur S
Biol Psychiatry; 2000 Apr; 47(7):670-6. PubMed ID: 10745061
[TBL] [Abstract][Full Text] [Related]
46. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Albinsson A; Palazidou E; Stephenson J; Andersson G
Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
[TBL] [Abstract][Full Text] [Related]
47. Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study.
Bergqvist PB; Dong J; Blier P
Psychopharmacology (Berl); 1999 Mar; 143(1):89-96. PubMed ID: 10227084
[TBL] [Abstract][Full Text] [Related]
48. Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: implications for the mechanism of action of clozapine.
Wadenberg ML; Ahlenius S; Svensson TH
Psychopharmacology (Berl); 1993; 110(3):273-9. PubMed ID: 7831419
[TBL] [Abstract][Full Text] [Related]
49. Directly Observable Behavioral Effects of Lorcaserin in Rats.
Serafine KM; Rice KC; France CP
J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
[TBL] [Abstract][Full Text] [Related]
50. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
[TBL] [Abstract][Full Text] [Related]
51. Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors.
Body S; Cheung TH; Bezzina G; Asgari K; Fone KC; Glennon JC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2006 Dec; 189(3):331-43. PubMed ID: 17051415
[TBL] [Abstract][Full Text] [Related]
52. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.
Wadenberg ML
Neurosci Biobehav Rev; 1996; 20(2):325-39. PubMed ID: 8811720
[TBL] [Abstract][Full Text] [Related]
53. Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated rats.
Salmi P; Malmgren K; Svensson TH; Ahlenius S
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):593-9. PubMed ID: 9686934
[TBL] [Abstract][Full Text] [Related]
54. Serotonergic modulation of extrapyramidal motor disorders in mice and rats: role of striatal 5-HT3 and 5-HT6 receptors.
Ohno Y; Imaki J; Mae Y; Takahashi T; Tatara A
Neuropharmacology; 2011; 60(2-3):201-8. PubMed ID: 20813116
[TBL] [Abstract][Full Text] [Related]
55. Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats.
Balsara JJ; Jadhav SA; Gaonkar RK; Gaikwad RV; Jadhav JH
Psychopharmacology (Berl); 2005 May; 179(3):597-605. PubMed ID: 15614572
[TBL] [Abstract][Full Text] [Related]
56. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
Basura GJ; Walker PD
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):66-77. PubMed ID: 11483243
[TBL] [Abstract][Full Text] [Related]
57. A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine.
Fletcher PJ
Pharmacol Biochem Behav; 1998 May; 60(1):55-60. PubMed ID: 9610924
[TBL] [Abstract][Full Text] [Related]
58. Potentiation of DOI-induced forward locomotion in rats by (-)-pindolol pretreatment.
Kaur P; Ahlenius S
J Neural Transm (Vienna); 1997; 104(6-7):605-14. PubMed ID: 9444561
[TBL] [Abstract][Full Text] [Related]
59. Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
Peacock L; Hansen L; Mørkeberg F; Gerlach J
Neuropsychopharmacology; 1999 Jan; 20(1):35-43. PubMed ID: 9885783
[TBL] [Abstract][Full Text] [Related]
60. Mediation of rat postejaculatory 22 kHz ultrasonic vocalization by dopamine D2 receptors.
Cagiano R; Barfield RJ; White NR; Pleim ET; Cuomo V
Pharmacol Biochem Behav; 1989 Sep; 34(1):53-8. PubMed ID: 2576313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
